Ultra-early response assessment in lymphoma treatment: [<sup>18</sup>F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.

导出 OA

翻译打印收藏纠错

第一作者： Marius E,Mayerhoefer

第一单位： Department of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. marius.mayerhoefer@meduniwien.ac.at.

作者： Marius E,Mayerhoefer ^[1] ; Markus,Raderer ^[2] ; Ulrich,Jaeger ^[2] ; Philipp,Staber ^[2] ; Barbara,Kiesewetter ^[2] ; Daniela,Senn ^[3] ; Ferdia A,Gallagher ^[4] ; Kevin,Brindle ^[5] ; Edit,Porpaczy ^[4] ; Michael,Weber ^[2] ; Dominik,Berzaczy ^[6] ; Ingrid,Simonitsch-Klupp ^[6] ; Christian,Sillaber ^[7] ; Cathrin,Skrabs ^[2] ; Alexander,Haug ^[2]

作者单位： Department of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. marius.mayerhoefer@meduniwien.ac.at. ^[1] Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. ^[2] Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. ^[3] Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. ^[4] Department of Radiology, Addenbrooke's Hospital, Cambridge, UK. ^[5] Department of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. ^[6] Institute of Pathology, Medical University Vienna, Vienna, Austria. ^[7]

关键词 Chemotherapy FDG Immunotherapy Lymphoma PET/MRI